ScinoPharm Taiwan Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,110	4,166	3,942	4,295	4,081
Cash & Short-Term Investments	3,110	4,166	3,942	4,295	4,081
Cash Growth	-25.35%	5.70%	-8.22%	5.24%	0.64%
Accounts Receivable	612.41	633.62	788.22	635.26	360.25
Other Receivables	11.62	20.57	25.23	18.28	32.8
Receivables	624.03	654.19	813.45	653.55	393.04
Inventory	1,637	1,673	1,512	1,189	1,345
Prepaid Expenses	119.99	114.91	105.79	132.24	96.85
Other Current Assets	0.09	-	8.3	51.13	50.71
Total Current Assets	5,491	6,608	6,381	6,320	5,967
Property, Plant & Equipment	4,083	4,426	4,399	4,498	4,648
Long-Term Investments	1,368	70.13	69.97	112.62	185.8
Other Intangible Assets	15.36	17.13	19.15	9.95	8.79
Long-Term Deferred Tax Assets	664.63	625.26	640.93	637.44	614.98
Other Long-Term Assets	236.22	196.6	211.48	332.96	267.07
Total Assets	11,858	11,943	11,722	11,911	11,691
Accounts Payable	62.53	82.17	102.46	126.5	70.86
Accrued Expenses	105.53	143.45	139.78	139.6	124.62
Short-Term Debt	130.42	35.56	32.14	77.6	-
Current Portion of Leases	23.46	19.64	17.56	17.89	16.17
Current Income Taxes Payable	14.5	11.5	62.6	99.64	71.17
Current Unearned Revenue	115.35	119.4	110.97	67.75	70.57
Other Current Liabilities	258.05	355.97	263.96	274.12	202.93
Total Current Liabilities	709.84	767.68	729.45	803.09	556.31
Long-Term Leases	608.78	620.34	570.23	581.18	540.27
Pension & Post-Retirement Benefits	10.69	23.61	54.51	74.49	79.55
Long-Term Deferred Tax Liabilities	0.63	1.3	1.66	-	0.35
Other Long-Term Liabilities	3.05	3.99	1.3	2.36	3.65
Total Liabilities	1,333	1,417	1,357	1,461	1,180
Common Stock	7,907	7,907	7,907	7,907	7,907
Additional Paid-In Capital	1,295	1,295	1,295	1,295	1,295
Retained Earnings	1,310	1,450	1,348	1,346	1,370
Comprehensive Income & Other	12.32	-126.18	-185.86	-98.18	-61.13
Shareholders' Equity	10,525	10,526	10,364	10,450	10,511
Total Liabilities & Equity	11,858	11,943	11,722	11,911	11,691
Total Debt	762.66	675.54	619.92	676.67	556.43
Net Cash (Debt)	2,347	3,490	3,322	3,618	3,524
Net Cash Growth	-32.75%	5.08%	-8.19%	2.65%	1.31%
Net Cash Per Share	2.96	4.40	4.19	4.56	4.45
Filing Date Shares Outstanding	790.74	790.74	790.74	790.74	790.74
Total Common Shares Outstanding	790.74	790.74	790.74	790.74	790.74
Working Capital	4,781	5,840	5,651	5,517	5,410
Book Value Per Share	13.31	13.31	13.11	13.22	13.29
Tangible Book Value	10,509	10,509	10,345	10,440	10,502
Tangible Book Value Per Share	13.29	13.29	13.08	13.20	13.28
Buildings	4,318	4,309	4,249	4,095	3,546
Machinery	6,862	6,647	6,432	6,249	5,641
Construction In Progress	52.08	194.04	77.72	155.62	1,119

Source: S&P Global Market Intelligence. Standard template. Financial Sources.